The landscape of metabolic healthcare in the United Kingdom is undergoing a significant transformation. Advances in endocrinology have led to the development of highly specialised injectable therapies that do more than just manage blood glucose—they fundamentally re-engineer how the body processes energy, manages hunger, and controls insulin response. Central to this new era of metabolic